Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 10, 2014 - Issue
Submit an article Journal homepage
102
Views
10
CrossRef citations to date
0
Altmetric
Review

Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?

Akito Kume1 KUME Clinic, Nagoya, Japan;2 Nagoya Clinical Neuropharmacology Laboratory, Nagoya, JapanCorrespondence[email protected]
Pages 249-262 | Published online: 03 Feb 2014

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.